» Articles » PMID: 26962215

Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection

Overview
Journal J Virol
Date 2016 Mar 11
PMID 26962215
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Dendritic cells (DCs) are major targets of filovirus infection in vivo Previous studies have shown that the filoviruses Ebola virus (EBOV) and Marburg virus (MARV) suppress DC maturation in vitro Both viruses also encode innate immune evasion functions. The EBOV VP35 (eVP35) and the MARV VP35 (mVP35) proteins each can block RIG-I-like receptor signaling and alpha/beta interferon (IFN-α/β) production. The EBOV VP24 (eVP24) and MARV VP40 (mVP40) proteins each inhibit the production of IFN-stimulated genes (ISGs) by blocking Jak-STAT signaling; however, this occurs by different mechanisms, with eVP24 blocking nuclear import of tyrosine-phosphorylated STAT1 and mVP40 blocking Jak1 function. MARV VP24 (mVP24) has been demonstrated to modulate host cell antioxidant responses. Previous studies demonstrated that eVP35 is sufficient to strongly impair primary human monocyte-derived DC (MDDC) responses upon stimulation induced through the RIG-I-like receptor pathways. We demonstrate that mVP35, like eVP35, suppresses not only IFN-α/β production but also proinflammatory responses after stimulation of MDDCs with RIG-I activators. In contrast, eVP24 and mVP40, despite suppressing ISG production upon RIG-I activation, failed to block upregulation of maturation markers or T cell activation. mVP24, although able to stimulate expression of antioxidant response genes, had no measurable impact of DC function. These data are consistent with a model where filoviral VP35 proteins are the major suppressors of DC maturation during filovirus infection, whereas the filoviral VP24 proteins and mVP40 are insufficient to prevent DC maturation.

Importance: The ability to suppress the function of dendritic cells (DCs) likely contributes to the pathogenesis of disease caused by the filoviruses Ebola virus and Marburg virus. To clarify the basis for this DC suppression, we assessed the effect of filovirus proteins known to antagonize innate immune signaling pathways, including Ebola virus VP35 and VP24 and Marburg virus VP35, VP40, and VP24, on DC maturation and function. The data demonstrate that the VP35s from Ebola virus and Marburg virus are the major suppressors of DC maturation and that the effects on DCs of the remaining innate immune inhibitors are minor.

Citing Articles

Peripheral immune responses to filoviruses in a reservoir versus spillover hosts reveal transcriptional correlates of disease.

Guito J, Arnold C, Schuh A, Amman B, Sealy T, Spengler J Front Immunol. 2024; 14:1306501.

PMID: 38259437 PMC: 10800976. DOI: 10.3389/fimmu.2023.1306501.


Understanding Host-Virus Interactions: Assessment of Innate Immune Responses in Cells after Arenavirus Infection.

Brinkmann N, Hoffmann C, Wurr S, Pallasch E, Hinzmann J, Ostermann E Viruses. 2022; 14(9).

PMID: 36146793 PMC: 9506377. DOI: 10.3390/v14091986.


Designing of a Multi-epitope Vaccine against the Structural Proteins of Marburg Virus Exploiting the Immunoinformatics Approach.

Sami S, Marma K, Mahmud S, Khan M, Albogami S, El-Shehawi A ACS Omega. 2021; 6(47):32043-32071.

PMID: 34870027 PMC: 8638006. DOI: 10.1021/acsomega.1c04817.


Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.

Pinski A, Woolsey C, Jankeel A, Cross R, Basler C, Geisbert T J Virol. 2021; 95(6).

PMID: 33408171 PMC: 8094945. DOI: 10.1128/JVI.01995-20.


High-Throughput Screening Assay to Identify Small Molecule Inhibitors of Marburg Virus VP40 Protein.

Luthra P, Anantpadma M, De S, Sourimant J, Davey R, Plemper R ACS Infect Dis. 2020; 6(10):2783-2799.

PMID: 32870648 PMC: 7793242. DOI: 10.1021/acsinfecdis.0c00512.


References
1.
Hartman A, Towner J, Nichol S . A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. Virology. 2004; 328(2):177-84. DOI: 10.1016/j.virol.2004.07.006. View

2.
Bray M, Geisbert T . Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol. 2005; 37(8):1560-6. DOI: 10.1016/j.biocel.2005.02.018. View

3.
Feagins A, Basler C . Amino Acid Residue at Position 79 of Marburg Virus VP40 Confers Interferon Antagonism in Mouse Cells. J Infect Dis. 2015; 212 Suppl 2:S219-25. PMC: 4564529. DOI: 10.1093/infdis/jiv010. View

4.
Edwards M, Liu G, Mire C, Sureshchandra S, Luthra P, Yen B . Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins. Cell Rep. 2016; 14(7):1632-1640. PMC: 4767585. DOI: 10.1016/j.celrep.2016.01.049. View

5.
Chang T, Kubota T, Matsuoka M, Jones S, Bradfute S, Bray M . Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog. 2009; 5(6):e1000493. PMC: 2696038. DOI: 10.1371/journal.ppat.1000493. View